Clinical Report of the Effectiveness of Netasurdil in Patients with Uveitic Glaucoma.
Sign Up to like & getrecommendations! Published in 2022 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2022.2145313
Abstract: The use of netasurdil 0.02% (Rhopressa) in patients with primary open-angle glaucoma has been shown to be effective in lowering intraocular pressure (IOP). However, the effectiveness of netasurdil in patients with secondary forms of glaucoma… read more here.
Keywords: netasurdil patients; effectiveness netasurdil; patients uveitic; uveitic glaucoma ... See more keywords